Critically ill patients with 2009 influenza A(H1N1) infection in Canada
- PMID: 19822627
- DOI: 10.1001/jama.2009.1496
Critically ill patients with 2009 influenza A(H1N1) infection in Canada
Abstract
Context: Between March and July 2009, the largest number of confirmed cases of 2009 influenza A(H1N1) infection occurred in North America.
Objective: To describe characteristics, treatment, and outcomes of critically ill patients in Canada with 2009 influenza A(H1N1) infection.
Design, setting, and patients: A prospective observational study of 168 critically ill patients with 2009 influenza A(H1N1) infection in 38 adult and pediatric intensive care units (ICUs) in Canada between April 16 and August 12, 2009.
Main outcome measures: The primary outcome measures were 28-day and 90-day mortality. Secondary outcomes included frequency and duration of mechanical ventilation and duration of ICU stay.
Results: Critical illness occurred in 215 patients with confirmed (n = 162), probable (n = 6), or suspected (n = 47) community-acquired 2009 influenza A(H1N1) infection. Among the 168 patients with confirmed or probable 2009 influenza A(H1N1), the mean (SD) age was 32.3 (21.4) years; 113 were female (67.3%) and 50 were children (29.8%). Overall mortality among critically ill patients at 28 days was 14.3% (95% confidence interval, 9.5%-20.7%). There were 43 patients who were aboriginal Canadians (25.6%). The median time from symptom onset to hospital admission was 4 days (interquartile range [IQR], 2-7 days) and from hospitalization to ICU admission was 1 day (IQR, 0-2 days). Shock and nonpulmonary acute organ dysfunction was common (Sequential Organ Failure Assessment mean [SD] score of 6.8 [3.6] on day 1). Neuraminidase inhibitors were administered to 152 patients (90.5%). All patients were severely hypoxemic (mean [SD] ratio of Pao(2) to fraction of inspired oxygen [Fio(2)] of 147 [128] mm Hg) at ICU admission. Mechanical ventilation was received by 136 patients (81.0%). The median duration of ventilation was 12 days (IQR, 6-20 days) and ICU stay was 12 days (IQR, 5-20 days). Lung rescue therapies included neuromuscular blockade (28% of patients), inhaled nitric oxide (13.7%), high-frequency oscillatory ventilation (11.9%), extracorporeal membrane oxygenation (4.2%), and prone positioning ventilation (3.0%). Overall mortality among critically ill patients at 90 days was 17.3% (95% confidence interval, 12.0%-24.0%; n = 29).
Conclusion: Critical illness due to 2009 influenza A(H1N1) in Canada occurred rapidly after hospital admission, often in young adults, and was associated with severe hypoxemia, multisystem organ failure, a requirement for prolonged mechanical ventilation, and the frequent use of rescue therapies.
Comment in
-
Mechanical ventilation in critically ill patients with 2009 influenza A(H1N1).JAMA. 2010 Mar 10;303(10):939-40; author reply 940-1. doi: 10.1001/jama.2010.197. JAMA. 2010. PMID: 20215605 No abstract available.
Similar articles
-
Critically Ill patients with 2009 influenza A(H1N1) in Mexico.JAMA. 2009 Nov 4;302(17):1880-7. doi: 10.1001/jama.2009.1536. Epub 2009 Oct 12. JAMA. 2009. PMID: 19822626
-
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.JAMA. 2009 Nov 4;302(17):1888-95. doi: 10.1001/jama.2009.1535. Epub 2009 Oct 12. JAMA. 2009. PMID: 19822628
-
Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary center intensive care unit experience from April to October 2009.Crit Care Med. 2010 Nov;38(11):2103-7. doi: 10.1097/CCM.0b013e3181f268f1. Crit Care Med. 2010. PMID: 20711068 Free PMC article.
-
2009 influenza A (H1N1): a clinical review.Hosp Pract (1995). 2010 Apr;38(2):74-81. Hosp Pract (1995). 2010. PMID: 20469616 Review.
-
Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis.Ann Card Anaesth. 2017 Jan-Mar;20(1):14-21. doi: 10.4103/0971-9784.197820. Ann Card Anaesth. 2017. PMID: 28074789 Free PMC article. Review.
Cited by
-
2009 pandemic influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement.Influenza Other Respir Viruses. 2012 Nov;6(6):e152-61. doi: 10.1111/j.1750-2659.2012.00410.x. Epub 2012 Jul 30. Influenza Other Respir Viruses. 2012. PMID: 22846046 Free PMC article.
-
The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.Crit Care. 2016 Mar 30;20:75. doi: 10.1186/s13054-016-1230-8. Crit Care. 2016. PMID: 27036638 Free PMC article.
-
Influenza A H1N1 2009 (Swine Flu) and Pregnancy.J Obstet Gynaecol India. 2011 Aug;61(4):386-93. doi: 10.1007/s13224-011-0055-2. Epub 2011 Sep 23. J Obstet Gynaecol India. 2011. PMID: 22851818 Free PMC article.
-
COVID-19: we must not forget about Indigenous health and equity.Aust N Z J Public Health. 2020 Aug;44(4):253-256. doi: 10.1111/1753-6405.13015. Epub 2020 Jul 6. Aust N Z J Public Health. 2020. PMID: 32628335 Free PMC article. No abstract available.
-
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccine.PLoS One. 2013;8(1):e47448. doi: 10.1371/journal.pone.0047448. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372640 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous